Bedel Financial Consulting’s Immunomedics Inc IMMU Stock Holding History

Bedel Financial Consulting’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-630	Closed	-$54K	–	899
2020 Q3	$54K	Sell	630 -10	-2%	-$506	0.03%	294
2020 Q2	$23K	Hold	640	–	–	0.01%	385
2020 Q1	$9K	Hold	640	–	–	0.01%	499
2019 Q4	$14K	Hold	640	–	–	0.01%	455
2019 Q3	$8K	Buy	640 +10	+2%	+$147	﹤0.01%	523
2019 Q2	$9K	Hold	630	–	–	0.01%	516
2019 Q1	$12K	Hold	630	–	–	0.01%	474
2018 Q4	$9K	Hold	630	–	–	0.01%	482
2018 Q3	$13K	Hold	630	–	–	0.01%	452
2018 Q2	$15K	Hold	630	–	–	0.01%	430
2018 Q1	$9K	Buy	+630	New	+$10.3K	0.01%	492

Bedel Financial Consulting's IMMU Position: Q4 2020 in Review

Bedel Financial Consulting sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 630 shares — an estimated $54K sold.

Bedel Financial Consulting first reported a position in IMMU in Q1 2018 and held it in 11 quarters. The position peaked at $54K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Bedel Financial Consulting reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Bedel Financial Consulting sold 630 Immunomedics Inc shares in Q4 2020, an estimated $54K.
Bedel Financial Consulting first reported a position in Immunomedics Inc in Q1 2018 and held it in 11 quarters.
Bedel Financial Consulting's Immunomedics Inc position peaked at $54K in Q3 2020.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Bedel Financial Consulting's 13F filing for Q4 2020, filed 2 Feb 2021.